GRI Bio ETF Top Insiders
| GRI Etf | USD 0.67 0.02 3.08% |
GRI Bio employs about 4 people. The company is managed by 5 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 0.8 employees per reported executive. Assessment of GRI Bio's management performance can provide insight into the Etf performance.
| Cristina White Executive Interim Officer |
| Albert Agro Founder CoFounder Officer |
GRI |
GRI Bio Management Team Effectiveness
The company has Return on Asset of (0.8253) % which means that on every $100 spent on assets, it lost $0.8253. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.8906) %, meaning that it generated no profit with money invested by stockholders. GRI Bio's management efficiency ratios could be used to measure how well GRI Bio manages its routine affairs as well as how well it operates its assets and liabilities.GRI Bio Workforce Comparison
GRI Bio is rated below average in number of employees as compared to similar ETFs. The total workforce of Health Care category is currently estimated at about 19,522. GRI Bio adds roughly 4.0 in number of employees claiming only tiny portion of all ETFs under Health Care category.
GRI Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GRI Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on GRI Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, GRI Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kelly Leanne over a year ago Acquisition by Kelly Leanne of 83333 shares of GRI Bio subject to Rule 16b-3 | ||
Agro Albert over a year ago Acquisition by Agro Albert of 172189 shares of GRI BIO subject to Rule 16b-3 |
GRI Bio Notable Stakeholders
A GRI Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GRI Bio often face trade-offs trying to please all of them. GRI Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GRI Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Albert Agro | CoFounder Officer | Profile | |
| Vipin Chaturvedi | CoFounder Officer | Profile | |
| Marc Hertz | President Director | Profile | |
| Leanne Kelly | CFO Secretary | Profile | |
| Cristina White | Interim Officer | Profile |
About GRI Bio Management Performance
The success or failure of an entity such as GRI Bio often depends on how effective the management is. GRI Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GRI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GRI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The investment seeks investment results that correspond generally to the performance, before the funds fees and expenses, of an index called the Cohen Steers Global Realty Majors Index. Cohen Steers is traded on Archipelago Exchange in USA.
The data published in GRI Bio's official financial statements typically reflect GRI Bio's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving GRI Bio's quantitative information. For example, before you start analyzing numbers published by GRI accountants, it's essential to understand GRI Bio's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
GRI Bio Workforce Analysis
Traditionally, organizations such as GRI Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GRI Bio within its industry.GRI Bio Manpower Efficiency
Return on GRI Bio Manpower
| Revenue Per Employee | 5.4M | |
| Revenue Per Executive | 4.4M | |
| Net Loss Per Employee | 3.3M | |
| Net Loss Per Executive | 2.6M | |
| Working Capital Per Employee | 59.2K | |
| Working Capital Per Executive | 47.4K |
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.